特殊医薬品の世界市場:基油別(鉱物油、合成油、バイオ系油)、製品別(エンジンオイル、ギアオイル、トランスミッションフルード、ブレーキフルード、クーラント、グリース)、車両別(乗用車、小型商用車、大型商用車)、地域別予測

◆英語タイトル:Global Speciality Pharmaceutical Market Size study, by Base oil (Mineral oil, Synthetic oil, Bio-based fluid), by Product (Engine oil, Gear oil, Transmission fluid, Brake fluid, Coolants, greases), by Vehicle (Passenger car, Light-weight Commercial Vehicle, Heavy-weight Commercial vehicle) and Regional Forecasts 2018-2025
◆商品コード:BZW9JN059
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2018年12月31日
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD3,950 ⇒換算¥422,650見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD5,550 ⇒換算¥593,850見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本資料は、特殊医薬品の世界市場について調べ、特殊医薬品の世界規模、市場動向、市場環境、基油別(鉱物油、合成油、バイオ系油)分析、製品別(エンジンオイル、ギアオイル、トランスミッションフルード、ブレーキフルード、クーラント、グリース)分析、車両別(乗用車、小型商用車、大型商用車)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。業界の主要なプレイヤーはPurdue Pharma、Tevu Pharma、SEP、Shire、Allergan、Mallickrodt、King Pharmaceutical、Alcon、Biogen idec、Forest、Gilead sciences、Lundbeck、Mundipharma、Servier、UCBなどです。
・イントロダクション
・エグゼクティブサマリー
・特殊医薬品の世界市場概要
・特殊医薬品の世界市場環境
・特殊医薬品の世界市場動向
・特殊医薬品の世界市場規模
・特殊医薬品の世界市場規模:基油別(鉱物油、合成油、バイオ系油)
・特殊医薬品の世界市場規模:製品別(エンジンオイル、ギアオイル、トランスミッションフルード、ブレーキフルード、クーラント、グリース)
・特殊医薬品の世界市場規模:車両別(乗用車、小型商用車、大型商用車)
・特殊医薬品の世界市場:地域別市場規模・分析
・特殊医薬品の北米市場規模・予測
・特殊医薬品のアメリカ市場規模・予測
・特殊医薬品のヨーロッパ市場規模・予測
・特殊医薬品のアジア市場規模・予測
・特殊医薬品の日本市場規模・予測
・特殊医薬品の中国市場規模・予測
・関連企業情報
【レポートの概要】

Global Speciality Pharmaceutical Market to reach USD 103.6 billion by 2025.

Global Speciality Pharmaceutical Market valued approximately USD 71 billion in 2017 is anticipated to grow with a healthy growth rate of more than 4.83% over the forecast period 2018-2025. The major driving factors of Speciality Pharmaceutical are High engine oil demand in vehicles, increasing automotive production and rising production of high-production lubricants. The rising demand for light and heavy commercial vehicles is also driving the markets of automotive lubricant. The adoption of bio-based lubricants which reduce harmful environmental effects is the current trend and it will boost the overall growth of the market. The major restraining factor extended drain intervals and introduction of electric vehicles are negatively impact the market of automotive lubricants. Speciality Pharmaceutical reduce friction between two surfaces of the components of a vehicle and exemplify the futuristic technologies, which are capable of manufacturing durable surfaces, maximizing overall efficiency while meeting environmental norms. These lubricants also help to control the vehicle temperature by absorbing the heat generated by moving parts of the vehicle and transferring it to the sump or cooler. The rising sales and production of automobiles in major developing regions, such as India, China, and Indonesia are to contribute to the growth of the Speciality Pharmaceutical market. Another benefit of an automated lubrication system is worker safety. It becomes unnecessary for employees to engage in the potentially hazardous practice. Automotive lubrication provides lubricant constantly at an appropriate amount that allows the bearing to operate at its optimum. Increasing demand in developing region is the major opportunity in the automotive lubricant market.
The regional analysis of Global Speciality Pharmaceutical Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia-Pacific accounted more than 42% share of total generating revenue in 2015 followed by Europe and North- America. Asia Pacific region is anticipated to exhibit higher growth rate / CAGR over the forecast period 2018-2025, due to increase in growth of the overall economy. The U.S. is a highly matured region for the industry with its dynamics influenced by high level of product innovation.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Base oil:

 Mineral oil
 Synthetic oil
 Bio-based fluid

By Product:

 Engine oil
 Gear oil
 Transmission fluid
 Brake fluid
 Coolants, greases

By Vehicle:

 Passenger car
 Light-weight Commercial Vehicle
 Heavy-weight Commercial vehicle

By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025

The industry is seeming to be fairly competitive. Some of the leading market players include,, Amsoil Inc., Bharat Petroleum Corporation Ltd., BP Plc., Chevron Corporation, China National Petroleum Corporation, China Petrochemical Corp., Exxon Mobil Corporation, Fuchs Petrolub SE, Grazpromneft-lubricants, Ltd., Gulf Oil Lubricants India Ltd., Hindustan Petroleum Corp. Ltd., Illinois Tool Works Inc. , Indian Oil Corporation Ltd., JXTG Nippon Oil & Energy corporation, Kluber Lubrication and so on. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Speciality Pharmaceutical Market in Market Study:

 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors

【レポートの目次】

TABLE OF CONTENTS
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
1.3.1. Speciality Pharmaceutical Market, by Type, 2015-2025 (USD Billion)
1.3.2. Speciality Pharmaceutical Market, by Application, 2015-2025 (USD Billion)
1.3.3. Speciality Pharmaceutical Market, by Region, 2015-2025 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Speciality Pharmaceutical Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Speciality Pharmaceutical Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Speciality Pharmaceutical Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Value Chain Analysis
4.3.1. Supplier
4.3.2. Manufacturers/Service Provider
4.3.3. Distributors
4.3.4. End-Users
4.4. Key Buying Criteria
4.5. Regulatory Framework
4.6. Cost Structure Analysis
4.6.1. Raw Material Cost Analysis
4.6.2. Manufacturing Cost Analysis
4.6.3. Labour Cost Analysis
4.7. Investment Vs Adoption Scenario
4.8. Analyst Recommendation & Conclusion
Chapter 5. Speciality Pharmaceutical Market, by Type
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Key Market Players
5.4. Speciality Pharmaceutical Market, Sub Segment Analysis
5.4.1. Oral Pharmaceuticals
5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.2. Parenteral Pharmaceuticals
5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.3. Transdermal Pharmaceuticals
5.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 6. Speciality Pharmaceutical Market, by Application
6.1. Market Snapshot
6.2. Market Performance – Potential Model
6.3. Key Market Players
6.4. Speciality Pharmaceutical Market, Sub Segment Analysis
6.4.1. Hospitals
6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.2. Retail Pharmacies
6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.3. Speciality Pharmacies
6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.4. Mail Order
6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 7. Speciality Pharmaceutical Market, by Regional Analysis
7.1. Speciality Pharmaceutical Market, Regional Market Snapshot (2015-2025)
7.2. North America Speciality Pharmaceutical Market Snapshot
7.2.1. U.S.
7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2. Canada
7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3. Europe Speciality Pharmaceutical Market Snapshot
7.3.1. U.K.
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2. Germany
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3. France
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4. Rest of Europe
7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4. Asia Speciality Pharmaceutical Market Snapshot
7.4.1. China
7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2. India
7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3. Japan
7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4. Rest of Asia Pacific
7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5. Latin America Speciality Pharmaceutical Market Snapshot
7.5.1. Brazil
7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2. Mexico
7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6. Rest of The World
7.6.1. South America
7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2. Middle East and Africa
7.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 8. Competitive Intelligence
8.1. Company Market Share (Subject to Data Availability)
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Purdue Pharma
8.3.1.1. Overview
8.3.1.2. Financial (Subject to Data Availability)
8.3.1.3. Product Summary
8.3.1.4. Recent Developments
8.3.2. Tevu Pharma
8.3.3. SEP
8.3.4. Shire
8.3.5. Allergan
8.3.6. Mallickrodt
8.3.7. King Pharmaceutical
8.3.8. Alcon
8.3.9. Biogen idec
8.3.10. Forest
8.3.11. Gilead sciences
8.3.12. Lundbeck
8.3.13. Mundipharma
8.3.14. Servier
8.3.15. UCB
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.1.6. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF SPECIALITY PHARMACEUTICAL MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF SPECIALITY PHARMACEUTICAL MARKET
TABLE 3. SPECIALITY PHARMACEUTICAL MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. SPECIALITY PHARMACEUTICAL MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
TABLE 7. SPECIALITY PHARMACEUTICAL MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)
TABLE 8. SPECIALITY PHARMACEUTICAL MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
TABLE 9. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 10. SPECIALITY PHARMACEUTICAL MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 11. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 12. SPECIALITY PHARMACEUTICAL MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 13. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 14. SPECIALITY PHARMACEUTICAL MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 15. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 16. SPECIALITY PHARMACEUTICAL MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 17. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 18. SPECIALITY PHARMACEUTICAL MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 19. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 20. SPECIALITY PHARMACEUTICAL MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 21. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 22. SPECIALITY PHARMACEUTICAL MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 23. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 24. SPECIALITY PHARMACEUTICAL MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 25. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 26. SPECIALITY PHARMACEUTICAL MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 27. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 28. SPECIALITY PHARMACEUTICAL MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 29. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 30. SPECIALITY PHARMACEUTICAL MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 31. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 32. SPECIALITY PHARMACEUTICAL MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 33. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 34. SPECIALITY PHARMACEUTICAL MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 35. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 36. SPECIALITY PHARMACEUTICAL MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 37. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 38. SPECIALITY PHARMACEUTICAL MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 39. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 40. SPECIALITY PHARMACEUTICAL MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 41. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 42. SPECIALITY PHARMACEUTICAL MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 43. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 44. SPECIALITY PHARMACEUTICAL MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 45. U.S. SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 46. U.S. SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 47. U.S. SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 48. U.S. SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 49. U.S. SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 50. CANADA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 51. CANADA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 52. CANADA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 53. CANADA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 54. CANADA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 55. UK SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 56. UK SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 57. UK SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 58. UK SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 59. UK SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 60. GERMANY SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 61. GERMANY SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 62. GERMANY SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 63. GERMANY SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 64. GERMANY SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 65. ROE SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 66. ROE SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 67. ROE SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 68. ROE SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 69. ROE SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 70. CHINA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 71. CHINA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 72. CHINA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 73. CHINA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 74. CHINA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 75. INDIA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 76. INDIA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 77. INDIA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 78. INDIA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 79. INDIA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 80. JAPAN SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 81. JAPAN SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 82. JAPAN SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 83. JAPAN SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 84. JAPAN SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 85. ROAPAC SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 86. ROAPAC SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 87. ROAPAC SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 88. ROAPAC SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 89. ROAPAC SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 90. BRAZIL SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 91. BRAZIL SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 92. BRAZIL SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 93. BRAZIL SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 94. BRAZIL SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 95. MEXICO SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 96. MEXICO SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 97. MEXICO SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 98. MEXICO SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 99. MEXICO SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 100. ROLA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 101. ROLA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 102. ROLA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 103. ROLA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 104. ROLA SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 105. ROW SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 106. ROW SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 107. ROW SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 108. ROW SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 109. ROW SPECIALITY PHARMACEUTICAL MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

FIG 1. SPECIALITY PHARMACEUTICAL MARKET, RESEARCH METHODOLOGY
FIG 2. SPECIALITY PHARMACEUTICAL MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. SPECIALITY PHARMACEUTICAL MARKET, KEY TRENDS 2016
FIG 5. SPECIALITY PHARMACEUTICAL MARKET, GROWTH PROSPECTS 2017-2025
FIG 6. SPECIALITY PHARMACEUTICAL MARKET, PORTERS 5 FORCE MODEL
FIG 7. SPECIALITY PHARMACEUTICAL MARKET, PEST ANALYSIS
FIG 8. SPECIALITY PHARMACEUTICAL MARKET, VALUE CHAIN ANALYSIS
FIG 9. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 10. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 11. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 12. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 13. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 14. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 15. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 16. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 17. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 18. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 19. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 20. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 21. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 22. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 23. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 24. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 25. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 26. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 27. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 28. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 29. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 30. SPECIALITY PHARMACEUTICAL MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 31. SPECIALITY PHARMACEUTICAL MARKET, REGIONAL SNAPSHOT 2015 & 2025
FIG 32. NORTH AMERICA SPECIALITY PHARMACEUTICAL MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 33. EUROPE SPECIALITY PHARMACEUTICAL MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 34. ASIA PACIFIC SPECIALITY PHARMACEUTICAL MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 35. LATIN AMERICA SPECIALITY PHARMACEUTICAL MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 36. SPECIALITY PHARMACEUTICAL MARKET, COMPANY MARKET SHARE ANALYSIS (2016)

【掲載企業】

Purdue Pharma、Tevu Pharma、SEP、Shire、Allergan、Mallickrodt、King Pharmaceutical、Alcon、Biogen idec、Forest、Gilead sciences、Lundbeck、Mundipharma、Servier、UCB

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[特殊医薬品の世界市場:基油別(鉱物油、合成油、バイオ系油)、製品別(エンジンオイル、ギアオイル、トランスミッションフルード、ブレーキフルード、クーラント、グリース)、車両別(乗用車、小型商用車、大型商用車)、地域別予測]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆